๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease

โœ Scribed by Dr Albert Wettstein


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
342 KB
Volume
13
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of physostigmine and lecithin on
โœ Dr. Bruce H. Peters; Harvey S. Levin ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 264 KB ๐Ÿ‘ 2 views

## Abstract Because there is evidence that central cholinergic mechanisms are depleted in dementia, we studied the effects of central cholinergic augmentation on the memory of 5 patients with Alzheimer disease. Patients received placebo, lecithin, physostigmine, or lecithin plus physostigmine in a

A double-blind, placebo-controlled singl
โœ Lisa Templeton; Andrew Barker; Keith Wesnes; David Wilkinson ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 2 views

Benzodiazepine agonists have been shown to reduce cognitive functioning by producing attentional deยฎcits similar to those produced by muscarinic antagonists. It has therefore been postulated that benzodiazepine antagonists may improve cognitive function in patients with Alzheimer's disease by indire

Effects of febuxostat versus allopurinol
โœ Schumacher, H. RALPH ;Becker, Michael A. ;Wortmann, Robert L. ;MacDonald, Patric ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB

## Abstract ## Objective To compare the urateโ€lowering efficacy and safety of febuxostat, allopurinol, and placebo in a large group of subjects with hyperuricemia and gout, including persons with impaired renal function. ## Methods Subjects (n = 1,072) with hyperuricemia (serum urate level โ‰ฅ8.0